1-N-[4-AMINOPHENYLETHANOYL]-6-O-[2-N-(4-BUTYLAMINO)-ETHYLAMINO]-NEAMINE
Compound with spectra: 1 NMR
![1-N-[4-AMINOPHENYLETHANOYL]-6-O-[2-N-(4-BUTYLAMINO)-ETHYLAMINO]-NEAMINE](/api/compound/5IUMDXJQMUM.png?ph=true&h=300&w=458 "1-N-[4-AMINOPHENYLETHANOYL]-6-O-[2-N-(4-BUTYLAMINO)-ETHYLAMINO]-NEAMINE")
| SpectraBase Compound ID | 5IUMDXJQMUM |
|---|---|
| InChI | InChI=1S/C26H47N7O7/c27-7-1-2-8-32-9-10-38-25-17(33-19(34)11-14-3-5-15(29)6-4-14)12-16(30)24(23(25)37)40-26-20(31)22(36)21(35)18(13-28)39-26/h3-6,16-18,20-26,32,35-37H,1-2,7-13,27-31H2,(H,33,34)/t16-,17+,18+,20+,21+,22+,23-,24+,25-,26+/m0/s1 |
| InChIKey | YOCWLSOCGYUXRU-ZHGZHUQRSA-N |
| Mol Weight | 569.7 g/mol |
| Molecular Formula | C26H47N7O7 |
| Exact Mass | 569.353697 g/mol |
| Enantiomer InChIKey | YOCWLSOCGYUXRU-BMHJOEDPSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
1-N-[3-AMINOPHENYLETHANOYL]-6-O-[2-N-(4-BUTYLAMINO)-ETHYLAMINO]-NEAMINE
1-N-[(S)-4-AMINO-2-HYDROXYBUTANOYL]-6-O-[2-N-(2-ETHYLAMINO)-ETHYLAMINO]-NEAMINE
1,3,6'-N-(TERT.-BUTOXYCARBONYL)-NEAMINE
3',6-DI-O-[(2-QUINOLYL)-METHYL]_NEAMINE
O-2-Amino-2-deoxy.beta.-D-glucopyranosyl-(1-4)-garamine
4',6-DI-O-[(2-NAPHTHYL)-METHYL]_NEAMINE
WCRQPRZWOABAGO-WPOHOJQESA-N
2-[4,6-bis(azanyl)-3-[3-azanyl-6-(1-hydroxyethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-2-oxidanyl-cyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
3',4'-DI-O-[(2-NAPHTHYL)-METHYL]_NEAMINE
2'-Carbobenzoxy-tobramycin
| Title | Journal or Book | Year |
|---|---|---|
| Design of Novel Antibiotics that Bind to the Ribosomal Acyltransfer Site | Journal of the American Chemical Society | 2002 |